Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502010635

Enzo Life Sciences HNMPA-(AM)3 (5mg). CAS: 120944-03-8
SDP

Supplier:  Enzo Life Sciences BMLEI2480005

Encompass_Preferred

HNMPA-(AM)3 is a cell-permeable analog of HNMPA. It inhibits insulin receptor tyrosine kinase activity (IC50=100 µM) and insulin-stimulated glucose oxidation in isolated rat adipocytes (IC50=10 µM). It has no effect on PKA (at concs. up to 1 mM) or PKC (at concs. up to 420 µM). Inhibits both serine and tyrosine autophosphorylation by the human insulin receptor. Does not affect protein kinase C (PKC) or cAMP-dependent protein kinase (PKA). Alternative name: Hydroxy-2-naphthalenylmethylphosphonic acid tri-acetoxymethyl ester. Purity: ≥98% (TLC). Solubility: Soluble in DMSO (>20mg/ml) or 100% ethanol (>20mg/ml). Long Term Storage: -20°C.

Catalog No. 50-201-0635


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.